KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Resmed (RMD) Raw Materials (2016 - 2025)

Resmed's Raw Materials history spans 16 years, with the latest figure at $374.7 million for Q4 2025.

  • For Q4 2025, Raw Materials rose 2.72% year-over-year to $374.7 million; the TTM value through Dec 2025 reached $374.7 million, up 2.72%, while the annual FY2025 figure was $367.3 million, 3.29% up from the prior year.
  • Raw Materials reached $374.7 million in Q4 2025 per RMD's latest filing, up from $363.4 million in the prior quarter.
  • In the past five years, Raw Materials ranged from a high of $468.8 million in Q1 2023 to a low of $145.4 million in Q1 2021.
  • Average Raw Materials over 5 years is $358.7 million, with a median of $366.0 million recorded in 2024.
  • Peak YoY movement for Raw Materials: skyrocketed 134.0% in 2022, then decreased 22.56% in 2024.
  • A 5-year view of Raw Materials shows it stood at $322.6 million in 2021, then soared by 43.66% to $463.4 million in 2022, then rose by 0.82% to $467.2 million in 2023, then fell by 21.92% to $364.8 million in 2024, then rose by 2.72% to $374.7 million in 2025.
  • Per Business Quant, the three most recent readings for RMD's Raw Materials are $374.7 million (Q4 2025), $363.4 million (Q3 2025), and $367.3 million (Q2 2025).